← All trials
NCT02694848
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2016
- Primary completion
- Dec 1, 2016
- Completion date
- Mar 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- China Academy of Chinese Medical SciencesLead sponsor
- China Academy of Chinese Medical SciencesReponsible party - principal investigator
- China Academy of Chinese Medical SciencesStudy chair
- Guangdong Provincial Hospital of Traditional Chinese MedicineCollaborator
- China Academy of Chinese Medical SciencesCollaborator
- People's Liberation Army of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.